Home

Schlummern Witzig Arbeiten rituximab rtx AIDS Peru Sicherheit

Efficacy and safety of different dosages of rituximab for refractory
Efficacy and safety of different dosages of rituximab for refractory

In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... |  Download Scientific Diagram
In vitro and in vivo treatment with rituximab (RTX) leads to CD20KO... | Download Scientific Diagram

Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic  Antibody–Associated Vasculitis with Severe Kidney Disease | American  Society of Nephrology
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology

Successful rituximab treatment of granulomatosis with polyangiitis with  cranial neuropathies | Inflammation and Regeneration | Full Text
Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text

Immunosuppressive therapy with rituximab in common variable  immunodeficiency | Clinical and Molecular Allergy | Full Text
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text

Increase in the density of CD20 improves the efficacy of rituximab (... |  Download Scientific Diagram
Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram

Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome |  The Journal of Rheumatology
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology

Current perspective on rituximab in rheumatic diseases | DDDT
Current perspective on rituximab in rheumatic diseases | DDDT

Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an  Inadequate Response to Prior Biologic Therapy: A Retrospective,  Single-Center Study - ACR Meeting Abstracts
Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts

Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat  oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX  in der täglichen Routine – rheuma-online
Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online

ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated  Vasculitis Patients - ACR Meeting Abstracts
ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts

A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage  Colony-Stimulating Factor Is an Effective Rescue for Patients with  Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology  of Blood and Marrow Transplantation
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation

Internalization of rituximab (RTX) to a highly variable extent,... |  Download Scientific Diagram
Internalization of rituximab (RTX) to a highly variable extent,... | Download Scientific Diagram

Non-Hodgkin Lymphoma | Encyclopedia MDPI
Non-Hodgkin Lymphoma | Encyclopedia MDPI

Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... |  Download Scientific Diagram
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram

Dosage regimen. Rituximab (RTX) and investigational drug (mycophenolate...  | Download Scientific Diagram
Dosage regimen. Rituximab (RTX) and investigational drug (mycophenolate... | Download Scientific Diagram

טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab  in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in  inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease  https://t.co/Ein148uebM"
טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease https://t.co/Ein148uebM"

Rituximab (RTX)- or ofatumumab (OFA)-opsonized target interaction... |  Download Scientific Diagram
Rituximab (RTX)- or ofatumumab (OFA)-opsonized target interaction... | Download Scientific Diagram

Effect of low-dose rituximab treatment on T- and B-cell lymphocyte  imbalance in refractory myasthenia gravis - ScienceDirect
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect

Percentage of apoptosis in untreated versus rituximab (RTX)-treated... |  Download Scientific Diagram
Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram

Long-term efficacy of maintenance therapy with Rituximab for IgG4-related  disease - European Journal of Internal Medicine
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease - European Journal of Internal Medicine

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based  biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine

Rituximab as Induction Therapy in Eosinophilic Granulomatosis with  Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A  36-Month Follow-Up Analysis - The Journal of Allergy and Clinical  Immunology: In Practice
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice

Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... |  Download Scientific Diagram
Del(17p) influences the pharmacokinetics of rituximab (RTX). Del(17p)... | Download Scientific Diagram

Interrupting rituximab treatment in relapsing-remitting multiple sclerosis;  no evidence of rebound disease activity - Multiple Sclerosis and Related  Disorders
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders